ebook Munafa Stock Market Course + Intraday & FNO calls  

       

VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE

Venus Remedies Limited Complete list of announcements declared & dividend announcements by Venus Remedies Limited VENUSREM_BE

Venus Remedies Limited VENUSREM_BE listed on NSE and deals in

Announcements and dividends declared by Venus Remedies Limited VENUSREM_BE

Venus Remedies trades 2% up on approval to market cancer drugs in Serbia
"The company has secured marketing authorisation from Serbia for gemcitabine and docetaxel, widely used chemotherapy drugs beneficial in the treatment of various types of cancer," the company said in a regulatory filing.
Announcement as on 20 September 2023

Venus Remedies gains on registering with govt body; to get custom duty exemption
"This exemption will not only enable us to reduce production costs but also empower us to invest more in research and development, enhancing our competitiveness and expanding our global reach," said Saransh Chaudhary, chief of research at Venus Remedies.
Announcement as on 14 September 2023

Buzzing Stocks: IRCTC, Bombay Dyeing, NBCC, Venus Remedies others in news today
Stocks to watch: Check out the companies making headlines before the opening bell, on September 14, 2023.
Announcement as on 14 September 2023

Venus Remedies gains 5% on Saudi Arabia’s marketing approval for anti-coagulant drug
The company has said it has so far secured marketing authorisations from Saudi Arabia for six antibiotics meant for intensive care units and three oncology products
Announcement as on 28 August 2023

Venus Remedies gets marketing approval for anticoagulant drug in Saudi Arabia
Venus Remedies on Monday said it has received approval to market a drug, which prevents blood clots, in Saudi Arabia. The company has received the marketing approval for Enoxaparin in pre-filled syringes, the drug firm said in a statement on Monday.
Announcement as on 28 August 2023

Announcements by Venus Remedies Limited first page | Next page | Prev page |

VENUSREM_BE Venus Remedies Limited current price & indicator signals

Moving Averages for Venus Remedies Limited

  • 5Day Average: 1866.6
  • 12Day Average: 1727.77
  • 20Day Average: 1313.06
  • 50Day Average: 977.95
  • 100Day Average: 807.69
  • 150Day Average: 685.59
  • 200Day Average: 577.62

VENUSREM_BE Indicators & signals

Indicator MACD (12,26,9)

1656.51, 1353.69, 252.27
Indicator MACD is in positive zone

Indicator ADX (14)

62.02, 49.71, 11.65
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 78
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of VENUSREM_BE Venus Remedies Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Tue Jun 2026 1833.50 1833.50 to 1930.00 -5% 0.68 times
29 Mon Jun 2026 1930.00 1855.10 to 2044.30 -0.87% 1.25 times
25 Thu Jun 2026 1947.00 1800.00 to 1947.10 4.99% 1.04 times
24 Wed Jun 2026 1854.40 1770.10 to 1856.50 4.88% 0.84 times
23 Tue Jun 2026 1768.10 1630.00 to 1776.20 4.5% 1.13 times
22 Mon Jun 2026 1691.90 1666.80 to 1775.00 -2.71% 0.77 times
19 Fri Jun 2026 1739.10 1703.00 to 1790.00 0% 0.59 times
18 Thu Jun 2026 1739.10 1691.10 to 1850.00 -1.99% 1.39 times
17 Wed Jun 2026 1774.50 1774.50 to 1850.00 -5% 0.57 times
16 Tue Jun 2026 1867.80 1805.50 to 1943.80 -0.81% 1.18 times
15 Mon Jun 2026 1883.00 1716.50 to 1887.30 167.15% 1.23 times
06 Fri Mar 2026 704.85 680.50 to 716.00 0.61% 0.13 times

Videos related to: VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE

 

Back to top